Investment Rating - The report does not explicitly provide an investment rating for the industry. Core Insights - Migrants accounted for nearly half of new HIV diagnoses in the EU/EEA in 2023, highlighting their vulnerability and the need for targeted health services [12][21] - Access to health services for undocumented migrants is inconsistent across the EU/EEA, which may hinder HIV prevention and treatment efforts [12][21] - The report emphasizes the importance of culturally and linguistically appropriate HIV prevention programs tailored for migrants [18] Summary by Sections Executive Summary - In 2023, migrants represented 47.9% of total HIV diagnoses in the EU/EEA, with significant barriers to accessing health services [12] - The report aims to assess the situation for migrants at risk of or living with HIV and the efforts made for their prevention [21] Methods - An online survey was conducted among EU/EEA Member States to collect data on the HIV epidemic among migrants and current national prevention interventions [13][32] Population Size - As of January 2023, over 61 million people in the EU/EEA were foreign-born, constituting 13% of the population [45] - The share of third-country nationals in the EU/EEA was approximately 6% [47] 95-95-95 Targets and Viral Suppression - Approximately 93% of migrants living with HIV in the EU/EEA were diagnosed, with 88% on treatment and 95% virally suppressed [51] - Only Luxembourg met the 2025 target of 86% viral suppression among migrants [51] Prevention Policies and Migrants - 27 EU/EEA countries reported having a national HIV prevention strategy, with 89% targeting migrants specifically [62] - Only 58% of these countries provided free condoms and lubricants for migrants [62]

Investment Rating - The report does not explicitly provide an investment rating for the industry Core Insights - The report highlights the need for improved efforts to address antimicrobial consumption in the EU/EEA, as current trends show insufficient progress towards established targets [4][18] Summary by Relevant Sections Antimicrobial Consumption Overview - In 2023, the EU population-weighted mean total consumption of antibacterials for systemic use was 20.0 DDD per 1,000 inhabitants per day, which is 1% higher than in 2019 [25] - The range of total antimicrobial consumption across countries varied from 9.6 DDD in the Netherlands to 28.5 DDD in Greece [25] - The percentage of WHO 'Access' group antibiotics consumed was 61.5% in 2023, which is 0.4 percentage points higher than in 2019 but 3.5 percentage points below the 2030 target of >65% [27] Community Sector Insights - The mean consumption of antibacterials in the community sector was 18.3 DDD per 1,000 inhabitants per day in 2023, with no statistically significant trend detected between 2019 and 2023 [25] - The most consumed subgroup of antibiotics in the community was penicillins (47%), followed by macrolides, lincosamides, and streptogramins (17%) [25] Hospital Sector Insights - In the hospital sector, the mean consumption of antibacterials was 1.6 DDD per 1,000 inhabitants per day in 2023, with no significant trend detected [25] - The proportion of 'broad-spectrum' antibiotics in the hospital sector was 40.1% in 2023, with no significant trend observed during the period [3] Progress Towards EU Targets - The EU aims to reduce total antibiotic consumption by 20% by 2030 compared to 2019 levels, targeting a reduction from 19.9 DDD to 15.9 DDD per 1,000 inhabitants per day [18] - Individual Member States have recommended reductions ranging from 3% to 27% based on their baseline consumption [18] Data Collection and Methodology - The report is based on data from 27 countries, including 25 EU Member States and two EEA countries, with data primarily sourced from sales and reimbursement reports [20][6] - The methodology employs the WHO ATC/DDD classification to standardize antimicrobial consumption metrics [6][8]

ISSN 2443-5228 2021 report on gender equality in the EU FREE THRIVE LEAD The European Commission is not liable for any consequence stemming from the reuse of this publication. Luxembourg: Publications Office of the European Union, 2021 © European Union, 2021 The reuse policy of European Commission documents is implemented by Commission Decision 2011/833/ EU of 12 December 2011 on the reuse of Commission documents (OJ L 330, 14.12.2011, p. 39). Unless otherwise noted, the reuse of this document is authorised ...